Rossari Biotech expands capacity at Dahej facility
Rossari Biotech Limited has commissioned an additional 20,000 MTPA capacity at its Dahej facility, effective September 26, 2025, bringing the company's total installed capacity to 152,500 MTPA. This expansion demonstrates Rossari Biotech's commitment to growth.
Concurrently, Unitop Chemicals Private Limited, a material subsidiary, has commissioned 15,000 MTPA of ethoxylation capacity at its Dahej facility, also effective September 26, 2025. This represents a portion of the total planned 30,000 MTPA expansion, increasing Unitop's total installed ethoxylation capacity to 51,000 MTPA.
The second phase of Unitop's expansion is projected for completion by Q3 FY26, indicating ongoing strategic investments in enhancing production capabilities.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when ROSSARI BIOTECH publishes news
Free account required • Unsubscribe anytime